Gunderson Dettmer advised Aldeyra Therapeutics, Inc. on a follow-on public offering of 5,250,000 shares at the price to the public of $13.75 per share for a…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
